Met Life Investment Management, LLC Xeris Biopharma Holdings, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 87,432 shares of XERS stock, worth $474,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,432
Previous 59,208
47.67%
Holding current value
$474,755
Previous $168,000
76.19%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$56.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$42.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$18.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$18.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$15.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $738M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...